Detalhe da pesquisa
1.
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
J Exp Clin Cancer Res
; 42(1): 99, 2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095531